Rich M, Zhao P, Nagulapally AB, Bond J, Saulnier Sholler G,  Bortezomib, a proteasome inhibitor, synergizes with DFMO to inhibit neuroblastoma cell proliferation via the reversal of the LIN28/Let-7 axis. American Association of Cancer Research (AACR) Annual Meeting, 2015.  Philadelphia, PA

Hayes D, Zhao P, Nagulapally AB, Bond J,2, Saulnier Sholler G, Tolcapone, a catechol-O-methyltransferase inhibitor, alone and in combination with oxaliplatin induces cell death in neuroblastoma. American Association of Cancer Research (AACR) Annual Meeting, 2015.  Philadelphia, PA

Cornelius A, Foley J, Mitchell D, Nagulapally A, Bond J, Huntelman M, Corneveaux J, Trent J, Saulnier Sholler G.  Sustained Clinical Response to Treatment Directed by Genomic Expression Profiling Suggests mTOR Signaling is an Effective Target in Choroid Plexus Carcinoma.   American Association of Cancer Research (AACR) M-Tor Meeting, September 2014.  Philadelphia, PA

Saulnier Sholler G, Bergendahl G, Vander Werff A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J, Hanna G, Merchant M, Huentelman M, Corneveaux J, Trent J.  A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma.  American Society [...]

Saulnier Sholler G, Eslin D.  Nifurtimox and radiation combination increases reactive oxygen species and induces apoptosis in medulloblastoma cells.  American Association for Cancer Research Pediatric Cancer at the Crossroads:  Translating Discovery into Improved Outcomes Meeting November 2013.  San Diego, CA

Kendzicky A, Rich M, Peck A, Zhao P, VanSickle E, McClung H, Chang A, Saulner Sholler G.  DFMO treatment affects the LIN28/Let-7 axis resulting in reduced glycolytic metabolism in Neuroblastoma.  American Association for Cancer Research Pediatric Cancer at the Crossroads:  Translating Discovery into Improved Outcomes Meeting November 2013.  San Diego, CA

Saulnier Sholler G, Bergendahl G, Vander Werff A, Dutta A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J, Hanna G, Merchant M, Huentelman M, Corneveaux J, Trent J.  A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma. American [...]

Saulnier Sholler G, Gerner E, Bergendahl G, LaFleur B, VanderWerff A, Ashilkaga T, Ferguson W,  Roberts W, Wada R, Eslin D, KravekaJ, Kaplan J, Mitchell D, Parikh N, Neville K, Sender L, Higgins T, Kawakita M, Hiramatsu K, Moriya S, Bachmann A.  A Phase 1 Trial of DFMO as a Single Agent and in Combination with Etoposide [...]

Eslin D, Lee C, Saulnier Sholler G, Sankpal U, Sutphin R, and Basha R. Nifurtimox and radiation for treating neuroblastoma: a pre-clinical study. American Association for Cancer Research Annual Meeting April 2013. Washington, DC.

Kendzicky A, Zhao P, Samal K, Yco L, McClung H, Gerner E, Bachmann A, Saulnier Sholler G. Targeting both ornithine decarboxylase and polyamine transport inhibits tumor growth in neuroblastoma. American Association for Cancer Research Annual Meeting April 2013. Washington, DC.